Sandbox 124: Difference between revisions
No edit summary |
No edit summary |
||
Line 60: | Line 60: | ||
residues in PBP2a; specifically | residues in PBP2a; specifically | ||
<scene name='37/372724/Tyr446_and_met641_label/2'>Tyr446 and Met641</scene>. | <scene name='37/372724/Tyr446_and_met641_label/2'>Tyr446 and Met641</scene>. | ||
As a result of ceftobiprole <scene name='37/372724/R2_interaction/4'>tighter binding</scene> to PBP2a as highlighted in green , <scene name='37/372724/ | As a result of ceftobiprole <scene name='37/372724/R2_interaction/4'>tighter binding</scene> to PBP2a as highlighted in green , <scene name='37/372724/Ceftobiprole_in_cpk/1'>the medicine</scene>, shown as colors of the atom types ([[CPK]]), is able to more efficiently react with the serine active site residue and therefore inhibit the activity of PBP2a. |